HUP0300551A2 - Pirido[3,2-e]-pirazinon-származékok alkalmazása merevedési zavar terápiája foszfodiészteráz 5 enzim gátlása útján és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Pirido[3,2-e]-pirazinon-származékok alkalmazása merevedési zavar terápiája foszfodiészteráz 5 enzim gátlása útján és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0300551A2 HUP0300551A2 HU0300551A HUP0300551A HUP0300551A2 HU P0300551 A2 HUP0300551 A2 HU P0300551A2 HU 0300551 A HU0300551 A HU 0300551A HU P0300551 A HUP0300551 A HU P0300551A HU P0300551 A2 HUP0300551 A2 HU P0300551A2
- Authority
- HU
- Hungary
- Prior art keywords
- phosphodiesterase
- erectile dysfunction
- compounds
- carbon atoms
- group
- Prior art date
Links
- 201000001881 impotence Diseases 0.000 title abstract 5
- 208000010228 Erectile Dysfunction Diseases 0.000 title abstract 3
- 102000011016 Type 5 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 title abstract 2
- 108010037581 Type 5 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 title abstract 2
- DCBOUXKSNFDXER-UHFFFAOYSA-N 1h-pyrido[2,3-b]pyrazin-2-one Chemical class C1=CC=C2NC(=O)C=NC2=N1 DCBOUXKSNFDXER-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 101001098806 Dictyostelium discoideum cGMP-specific 3',5'-cGMP phosphodiesterase 3 Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10012373A DE10012373A1 (de) | 2000-03-14 | 2000-03-14 | Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion |
PCT/EP2001/002485 WO2001068097A1 (de) | 2000-03-14 | 2001-03-06 | VERWENDUNG VON PYRIDO[3,2-e]-PYRAZINONEN ALS INHIBITOREN DER PHOSPHODIESTERASE 5 ZUR THERAPIE VON EREKTILER DYSFUNKTION |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0300551A2 true HUP0300551A2 (hu) | 2003-07-28 |
Family
ID=7634668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300551A HUP0300551A2 (hu) | 2000-03-14 | 2001-03-06 | Pirido[3,2-e]-pirazinon-származékok alkalmazása merevedési zavar terápiája foszfodiészteráz 5 enzim gátlása útján és ezeket tartalmazó gyógyszerkészítmények |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1267877A1 (ja) |
JP (1) | JP2003528056A (ja) |
AR (1) | AR028250A1 (ja) |
AU (1) | AU2001244192A1 (ja) |
BG (1) | BG107077A (ja) |
BR (1) | BR0109163A (ja) |
CZ (1) | CZ20023078A3 (ja) |
DE (1) | DE10012373A1 (ja) |
HU (1) | HUP0300551A2 (ja) |
IL (1) | IL151646A0 (ja) |
NO (1) | NO20024364L (ja) |
RU (1) | RU2002127413A (ja) |
SK (1) | SK13232002A3 (ja) |
WO (1) | WO2001068097A1 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
CN101848893B (zh) | 2007-09-14 | 2012-06-06 | 奥梅-杨森制药有限公司 | 1,3-二取代的4-(芳基-x-苯基)-1h-吡啶-2-酮 |
EA017648B1 (ru) | 2007-09-14 | 2013-02-28 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны |
AU2008329775A1 (en) | 2007-11-30 | 2009-06-04 | Biotie Therapies Gmbh | Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
US8691849B2 (en) | 2008-09-02 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
BRPI1012870B8 (pt) | 2009-05-12 | 2021-05-25 | Addex Pharmaceuticals Sa | derivados de 1,2,4-triazolo[4,3-a]piridina e seu uso como moduladores alostericos positivos de receptores de mglur2 e composição farmacêutica |
MY153912A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 1, 2, 4,-triazolo[4,3-a[pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
CA2814998C (en) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
BR112014031730B1 (pt) * | 2012-06-18 | 2023-05-16 | Dart Neuroscience (Cayman) Ltd | Compostos ou sais farmaceuticamente aceitáveis dos mesmos e seu uso |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
SI3431106T1 (sl) | 2014-01-21 | 2021-03-31 | Janssen Pharmaceutica Nv | Kombinacije, ki vsebujejo pozitivne alosterične modulatorje metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba |
UA121965C2 (uk) | 2014-01-21 | 2020-08-25 | Янссен Фармацевтика Нв | Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування |
JP6420400B2 (ja) * | 2017-04-12 | 2018-11-07 | ダート・ニューロサイエンス・(ケイマン)・リミテッド | 置換ピリジンアゾロピリミジン−5−(6h)−オン化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055465A (en) * | 1989-05-31 | 1991-10-08 | Berlex Laboratories, Inc. | Imidazoquinoxalinones, their aza analogs and process for their preparation |
AU3767793A (en) * | 1992-04-03 | 1993-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
DE4228095A1 (de) * | 1992-08-24 | 1994-03-03 | Asta Medica Ag | Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung |
DE4338948A1 (de) * | 1993-11-15 | 1995-05-18 | Carlen Judith | Verwendung von PDE-Inhibitoren bei der Behandlung erektiler Dysfunktionen |
DE19510965A1 (de) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung |
DE19728301A1 (de) * | 1997-07-03 | 1999-01-07 | Dresden Arzneimittel | Verwendung von Inhibitoren der Phosphodiesterase 4 für die Behandlung der allergischen Rhinitis |
-
2000
- 2000-03-14 DE DE10012373A patent/DE10012373A1/de not_active Withdrawn
-
2001
- 2001-03-06 JP JP2001566661A patent/JP2003528056A/ja active Pending
- 2001-03-06 SK SK1323-2002A patent/SK13232002A3/sk unknown
- 2001-03-06 RU RU2002127413/04A patent/RU2002127413A/ru unknown
- 2001-03-06 EP EP01917067A patent/EP1267877A1/de not_active Withdrawn
- 2001-03-06 WO PCT/EP2001/002485 patent/WO2001068097A1/de not_active Application Discontinuation
- 2001-03-06 CZ CZ20023078A patent/CZ20023078A3/cs unknown
- 2001-03-06 IL IL15164601A patent/IL151646A0/xx unknown
- 2001-03-06 AU AU2001244192A patent/AU2001244192A1/en not_active Abandoned
- 2001-03-06 HU HU0300551A patent/HUP0300551A2/hu unknown
- 2001-03-06 BR BR0109163-8A patent/BR0109163A/pt not_active Application Discontinuation
- 2001-03-13 AR ARP010101174A patent/AR028250A1/es unknown
-
2002
- 2002-09-10 BG BG107077A patent/BG107077A/bg unknown
- 2002-09-12 NO NO20024364A patent/NO20024364L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1267877A1 (de) | 2003-01-02 |
BR0109163A (pt) | 2002-11-26 |
RU2002127413A (ru) | 2004-02-27 |
AU2001244192A1 (en) | 2001-09-24 |
SK13232002A3 (sk) | 2003-05-02 |
JP2003528056A (ja) | 2003-09-24 |
IL151646A0 (en) | 2003-04-10 |
NO20024364L (no) | 2002-09-27 |
WO2001068097A1 (de) | 2001-09-20 |
NO20024364D0 (no) | 2002-09-12 |
CZ20023078A3 (cs) | 2003-03-12 |
BG107077A (bg) | 2003-05-30 |
DE10012373A1 (de) | 2001-09-20 |
AR028250A1 (es) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300551A2 (hu) | Pirido[3,2-e]-pirazinon-származékok alkalmazása merevedési zavar terápiája foszfodiészteráz 5 enzim gátlása útján és ezeket tartalmazó gyógyszerkészítmények | |
DE59610077D1 (de) | Phenyldihydrobenzofurane | |
MY140872A (en) | 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibitory activity, compositions containing such derivatives and the use of such derivatives in the treatment of hypertension and other disorders | |
DE69911448D1 (de) | Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen | |
MY128479A (en) | (beta)-carboline derivatives useful as inhibitors of phosphodiesterase | |
NO20010743L (no) | Antivirale indoloksoacetyl-piperazin-derivater | |
BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
BR9911060A (pt) | Composições compreendendo mono- ou dinitrato orgânico para tratar impotência | |
YU60903A (sh) | Kompozicija i antivirusna aktivnost derivata supstituisanog azaindoloksoacetat piperazina | |
GEP20053510B (en) | Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors | |
WO2003070283A3 (en) | Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent | |
AU6872701A (en) | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives | |
BR0010181A (pt) | Composição farmacêutica de dosagem unitária e seu uso | |
MY146549A (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
IL156827A (en) | Derivatives of 2-mercapto- [3,1] thiazolo [4,5 [b- pyridine and pharmaceutical preparations containing them for the treatment of cardiovascular disease | |
ATE230404T1 (de) | Cyclohexyldihydrobenzofurane | |
PT1109814E (pt) | 5-heterociclil pirazol¬4,3-d|pirimidina-7-onas para o tratamento da disfuncao erectil masculina | |
BR0110373A (pt) | Inibidores da enzima fosfodiesterase (pde) e seu uso em artigos farmacêuticos industrializados | |
TW200635925A (en) | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents | |
TW200505448A (en) | 5-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents | |
HUP0402241A2 (hu) | Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére | |
HUP0301915A2 (hu) | Sildenafil és egyéb PDE5 inhibitor hatású vegyületek alkalmazása korai magömlés kezelésére szolgáló gyógyszerkészítmény elżállítására | |
GEP20094596B (en) | Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction |